[Federal Register Volume 89, Number 32 (Thursday, February 15, 2024)]
[Notices]
[Page 11844]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-03106]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Office of the Secretary; Notice of Meeting

    Pursuant to section 1009 of the Federal Advisory Committee Act, as 
amended, notice is hereby given of a meeting of the Muscular Dystrophy 
Coordinating Committee (MDCC).
    The meeting will be held as a virtual meeting and will be open to 
the public as indicated below. Individuals who plan to view the virtual 
meeting and need special assistance or other reasonable accommodations 
to view the meeting, should notify the Contact Person listed below in 
advance of the meeting. The meeting can be accessed from the NIH 
Videocast at the following link: https://videocast.nih.gov/.

    Name of Committee: Muscular Dystrophy Coordinating Committee.
    Date: March 18, 2024.
    Time: 12:00 p.m. to 4:00 p.m. ET.
    Agenda: The purpose of this meeting is to bring together 
committee members, representing government agencies, patient 
advocacy groups, other voluntary health organizations, and patients 
and their families to update one another on progress relevant to the 
Action Plan for the Muscular Dystrophies and to coordinate 
activities and discuss gaps and opportunities leading to better 
understanding of the muscular dystrophies, advances in treatments, 
and improvements in patients' and their families' lives. The agenda 
for this meeting will be available on the MDCC website: https://www.mdcc.nih.gov/.
    Registration: To register, please go to: https://roseliassociates.zoomgov.com/meeting/register/vJItc-6hrTsuHDK-RDbVsTHLsMoFRuqyoRw#/registration.
    Webcast Live: https://videocast.nih.gov/.
    Place: National Institutes of Health, Neuroscience Center, 6001 
Executive Boulevard, Rockville, MD 20852 (Virtual Meeting).
    Contact Person: Glen Nuckolls, Ph.D., Program Director, National 
Institute of Neurological, Disorders and Stroke (NINDS), NIH, 6001 
Executive Blvd., Bethesda, MD 20892, 301-496-5876, <a href="/cdn-cgi/l/email-protection#99d4dddadad9f7f0f1b7fef6ef"><span class="__cf_email__" data-cfemail="a8e5ecebebe8c6c1c086cfc7de">[email protected]</span></a>.

    Any interested person may file written comments with the 
committee by forwarding the statement to the Contact Person listed 
on this notice. The statement should include the name, address, 
telephone number and when applicable, the business or professional 
affiliation of the interested person.
    Anyone from the public can attend the meeting virtually via the 
NIH Videocasting website (https://videocast.nih.gov). Please 
continue checking these websites, in addition to the committee 
website listed below, for the most up to date guidance as the 
meeting date approaches.
    More information can be found on the Muscular Dystrophy 
Coordinating Committee website: https://mdcc.nih.gov/.

    Dated: February 9, 2024.
Miguelina Perez,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2024-03106 Filed 2-14-24; 8:45 am]
BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>